Catheter Precision, Inc.
VTAK
$2.12
$0.073.42%
AMEX
| 09/30/2025 | 06/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 6.60% | 48.25% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 6.60% | 48.25% | |||
| Cost of Revenue | 28.57% | 27.27% | |||
| Gross Profit | 5.05% | 50.00% | |||
| SG&A Expenses | 2.50% | -17.33% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 6.46% | -15.25% | |||
| Operating Income | -6.45% | 17.88% | |||
| Income Before Tax | 64.64% | -34.37% | |||
| Income Tax Expenses | 108.21% | -31.22% | |||
| Earnings from Continuing Operations | 57.05% | -34.93% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -73.35% | -- | |||
| Net Income | 55.94% | -26.30% | |||
| EBIT | -6.45% | 17.88% | |||
| EBITDA | -7.97% | 21.06% | |||
| EPS Basic | 76.23% | -5.28% | |||
| Normalized Basic EPS | 71.46% | 28.27% | |||
| EPS Diluted | 76.23% | -5.28% | |||
| Normalized Diluted EPS | 71.46% | 28.27% | |||
| Average Basic Shares Outstanding | 85.35% | 19.97% | |||
| Average Diluted Shares Outstanding | 85.35% | 19.97% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||